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Objectives 
! Review the epidemiology and trends of diabetes
! Discuss the pathophysiology of diabetes
! Delineate treatment strategies including lifestyle modification
and medications
Epidemiology 
! 11.3% of those over the age of 20 living with DM2 in the US1 
! World Health Organization estimates 7th leading cause of 
death by 20302 
! More than $300 billion spent on diabetes-related medical 
costs in 20123 
1. Centers for Disease Control and Prevention. National diabetes fact sheet: national estimates and general 
information on diabetes and prediabetes in the United States, 2011. Atlanta, GA: U.S. Department of Health and 
Human Services, Centers for Disease Control and Prevention, 2011. 
2. World Health Organization. Diabetes Fact Sheet No. 312. Reviewed October 2013. 
www.who.int/mediacentre/factsheets/fs312/en/. Accessed May 9, 2014. 
3. American Diabetes Association. Economic costs of diabetes in the U.S. in 2012. Diabetes Care 
2013;36:1033-1046. 
CDC Fact Sheet 
DM2 Epidemiology 
! 90% of those with diabetes in the US, Canada, and Europe 
have type 2 diabetes 
County-level Estimates of Diagnosed Diabetes among Adults aged ≥ 20 years:  
United States 2004 
County-level Estimates of Diagnosed Diabetes among Adults aged ≥ 20 years:  
United States 2011 

! Number of people with diabetes has more than doubled in 
the past 20 years 
! Concerning is the number of new diagnoses in children and 
adolescents 
! Need to work on prevention with focus on social and 
environmental factors  
What is diabetes?  
Definition of Diabetes 
! Group of diseases resulting in elevated blood glucose levels  
!  Involves insufficient insulin or decreased response to insulin 
resulting in elevated blood glucose 
! Glucose is the energy source for the cells 
 
www.mayoclinic.org/diseases-conditions/diabetes/basics/definitions 
Types of Diabetes  
! Type 1 Diabetes (DM1) 
! Type 2 Diabetes (DM2) 
! Prediabetes 
! Gestational Diabetes  
DM1 
! Autoimmune destruction of 
insulin producing beta cells in 
pancreas 
!  Insulin dependent  
! Typically childhood onset 





Nobel Prize in 1923 
Insulin 
! Hormone that regulates the amount 
of glucose in the blood  
! Produced by beta cells in pancreas  
! Beta cells release insulin with each 




!  Impaired fasting glucose or impaired glucose tolerance 
!  Increased risk for developing DM2 
! Annual screening for diabetes recommended 
!  Intensive lifestyle modifications recommended 
DM2 
!  Inadequate insulin production OR 
!  Insulin resistance OR 
!  Inadequate insulin production AND insulin resistance 
! Linked to obesity  
!  Increased risk if African, Asian, Native American, Latino, or 
Pacific Islander 
Gestational DM 
!  Increased risk if overweight or obese prior to pregnancy 
! Affects 2 – 10% of women during pregnancy 
!  Increases risk of DM2 
Summary 
! Diabetes increasing in prevalence 
! 4 Types: DM1, DM2, Prediabetes, and Gestational Diabetes 





1.  Impaired Insulin Secretion 
2.  Hyperglycemia 
3.  Insulin Resistance 
Metabolic Defects 
! Decreased glucose transport and utilization at the level of the 
muscle and adipose tissue 
!  Increased glucose production by the liver 
! Decreased insulin secretion by the pancreas 
What organs are involved? 
! Pancreas: beta cells secrete insulin and amylin, alpha cells 
secrete glucagon 
! GI Tract: secrete GLP-1 to signal beta cells to increase 
insulin and alpha cells to decrease glucagon 
! Liver: stores glucose as glycogen, supplies glucose via 
glyconeogenesis and gluconeogenesis 
! Muscles and adipose tissue: remove glucose from the blood  
! Adrenal glands: secrete epinephrine and cortisol  
Insulin Secretion 
! From beta cells in pancreas 
! Decreases over time in DM2 
! May be exacerbated by hyperglycemia  
Alpha and Beta Cells in Pancreas 
dtc.ucsf.edu 
Insulin Resistance 
! Likely genetic component 
! Exacerbated by inflammatory particles secreted by adipose 
tissue (leptin adiponectin, tumor necrosis factor alpha, and 
resistin) 
dtc.ucsf.edu 
Insulin and Glucagon 
Glucagon 
! Produced by alpha cells in pancreas 
! Serves as counterbalance to insulin 
! Signal liver to initiate glyconeogenesis  
 




! Released from gut  
! Signal beta cells to 
increase insulin and 
decrease glucagon  





! Released from gut  
! Signal beta cells to 
increase insulin and 
decrease glucagon  
Epinephrine and Cortisol 
dtc.ucsf.edu 
What organs are involved? 
! Pancreas: beta cells secrete insulin and amylin, alpha cells 
secrete glucagon 
! GI Tract: secrete GLP-1 to signal beta cells to increase 
insulin and alpha cells to decrease glucagon 
! Liver: stores glucose as glycogen, supplies glucose via 
glyconeogenesis and gluconeogenesis 
! Muscles and adipose tissue: remove glucose from the blood  
! Adrenal glands: secrete epineprhine and cortisol  
Genetic Causes 
! Lifetime risk of DM2 is 5-10 times higher in first-degree 
relatives 
!  Increased prevalence in certain ethnic groups, including 
people of Hispanic, African, and Asian decent  
 
Environmental Causes  
! Food sources 
! Activity levels  
! Built environment 
! Need to recognize implications of built, food, school, and 
work environments 
! Greater impact on groups with lower socioeconomic status 
Summary 
! Diabetes is the resultant hyperglycemia from inadequate 
insulin secretion, insulin resistance, or both 
!  It is progressive, with continual beta cell decline over time 





! Approach normoglycemia for most patients to decrease risk 
of microvascular and macrovascular complications 
Treatment Strategies 
1.  Lifestyle modifications: weight loss, dietary changes, 
increased physical activity 
2.  Self-monitoring 
3.  Medications: oral medications, injectable non-insulin 
medications, insulin 
4.  Screening for and preventing complications 
! Tailored approach to treatment based on age, comorbidities, 
and availability of resources 
 
Depiction of the elements of decision making used to determine appropriate efforts to 
achieve glycemic targets.  
Inzucchi S E et al. Dia Care 2012;35:1364-1379 
Copyright © 2011 American Diabetes Association, Inc. 
Lifestyle Modifications 
! Low carbohydrate diets 
!  Increased physical activity 
! Weight loss  
! Bariatric surgery  
Bariatric surgery 
! Patients followed for 15 years after surgery 
! Associated with increased likelihood of long-term remission 
and decreased rates of microvascular and macrovascular 
complications  
Sjostrom L, Peltonen M, Jacobson P, et al. Association of bariatric surgery with long-term remission of type 2 diabetes and 
with microvascular and macrovascular complications. JAMA 2014;311(22):2297-2304.  
Diabetes Super Foods 
! Beans 
! Green leafy vegetables 
! Sweet potatoes 
! Berries 
! Fish rich in omega 3 Fatty acids 




County-level Estimates of Leisure-time Physical Inactivity among Adults aged ≥ 20 years:                                                       
United States 2004 
County-level Estimates of Leisure-time Physical Inactivity among Adults aged ≥ 20 years:                                                       
United States 2011 

DM Management 
! Requires patient-activation and patient-clinician partnerships 
 
! Gradual decline of beta cell function over time warrants 




! Monitoring and recording blood glucose 
! Keeping a log book of glucose readings 
! Regular foot checks  
! Laboratory tests 
Hemoglobin A1c 
! Glucose attaches to hemoglobin -> glycosylated hemoglobin 
! Provides estimate of average glucose over the past 3 months 
! May not be accurate if hemoglobin mutation 
Medications  
Source: 2007–2009 National Health Interview Survey. 
Metformin 
! First line oral agent 
! Decreases hepatic glucose production 
!  Insulin sensitizer 
! Shown to decrease mortality 
Sulfonylureas 
! Bind to component of ATP-dependent potassium channel in 
pancreatic beta cell (sulfonylurea 1 receptor) 
! Stimulate insulin secretion from the pancreas 
!  Include glipizide, glyburide, gliclazide, and glimepiride 
Incretin Based Therapies (DPP-4 
Inhibitors, GLP-1 Agonist) 
! DPP-4 inhibitors result in increased 
GLP-1 
! GLP-1 is produced by small 
intestines in response to food 
! GLP-1 Agonists bind to GLP-1 
receptors and stimulate insulin 
release 
! Both mechanisms achieve same 
goal of glucose-dependent insulin 
release from pancreas 
Thiazolidinediones 
!  Increase insulin sensitivity to remove glucose from the blood 
stream   
! Act on muscles, adipose tissue, and the liver to increase 
glucose use and decrease glucose production  
! Mechanism not fully understood 
! Bind to peroxisome proliferator-activated receptors to 
regulate gene expression 
Insulin 
! Secreted with meals and in a pulsatile 
manner for basal level 
 
! ~50% of insulin secretion is basal with the 
remaining being secreted around meals  
Types of Insulin  
! Rapid-acting 
! Regular or Short-acting 
!  Intermediate-acting 
! Long-acting 
Modes of Insulin Administration 
!  Injection from insulin in bottle 
!  Injection from insulin pen 
!  Insulin pumps  
! More flexibility in dosing 
!  Fewer highs and lows  
Why is insulin not a pill? 
!  Insulin would be inactivated in the digestive system 
! Needs to be injected to enter bloodstream 
Summary 
! Most effective treatment strategies combine lifestyle 
changes, self-care, medications, and prevention of 
complications 
! Most patients will eventually require insulin given progressive 
nature of the disease  
How has treatment changed in the 
21st century?   
! Creation of additional oral medications 
! More sophisticated insulin pumps 
!  Increased use of bariatric surgery  
! Technology support for self management (telehealth, patient 
portals) 
Innovations in Technology  
Glooko.com 
More to come" 
! Genetic testing to identify predisposition and which 
medications will be most effective  
! New oral and injectable medications 
! Health policy for prevention 
! More pancreas transplants? 
Institute for Healthcare 
Improvement Triple Aim 
http://www.ihi.org/Engage/Initiatives/TripleAim/Pages/default.aspx 
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